UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

International journal of cancer, 2010-11, Vol.127 (9), p.2209-2221

2010

Volltextzugriff (PDF)

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

Journal of translational medicine, 2011-05, Vol.9 (1), p.70-70, Article 70

2011

Volltextzugriff (PDF)

First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology

European respiratory review, 2014-03, Vol.23 (131), p.92-105

2014

Volltextzugriff (PDF)

Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group

American journal of ophthalmology, 2016-08, Vol.168, p.217-226

2016

Volltextzugriff (PDF)

How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy

American journal of obstetrics and gynecology, 2015-08, Vol.213 (2), p.206.e1-206.e5

2015

Volltextzugriff (PDF)

Association of Epidermal Growth Factor Receptor Polymorphism, Skin Toxicity, and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment

Clinical cancer research, 2010-01, Vol.16 (1), p.304-310

2010

Volltextzugriff (PDF)

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Journal of clinical oncology, 2005-09, Vol.23 (27), p.6747-6755

2005

Volltextzugriff (PDF)

Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma

European journal of cancer (1990), 2011-03, Vol.47 (5), p.690-696

2011

Volltextzugriff (PDF)

Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy

Blood, 2003-09, Vol.102 (5), p.1930-1930

2003

Volltextzugriff (PDF)

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study

Cancer Immunology, Immunotherapy, 2007-10, Vol.56 (10), p.1637-1644

2007

Volltextzugriff (PDF)

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

Cancer biology & therapy, 2010-11, Vol.10 (9), p.860-864

2010

Volltextzugriff (PDF)

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

Lung cancer (Amsterdam, Netherlands), 2007-01, Vol.55 (1), p.109-113

2007

Volltextzugriff (PDF)

Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma

Clinical cancer research, 2007-02, Vol.13 (4), p.1171-1178

2007

Volltextzugriff (PDF)

Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

Clinical cancer research, 2004-03, Vol.10 (5), p.1605-1612

2004

Volltextzugriff (PDF)

The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum

Fertility and sterility, 2009-11, Vol.92 (5), p.1748.e1-1748.e4

2009

Volltextzugriff (PDF)

Bowel perforation in non-small cell lung cancer after bevacizumab therapy

Investigational new drugs, 2009-04, Vol.27 (2), p.184-187

2009

Volltextzugriff (PDF)

Second-line therapy for small-cell lung cancer

Expert review of anticancer therapy, 2011-04, Vol.11 (4), p.631-637

Schmittel, Alexander

2011

Volltextzugriff (PDF)

A Patient with Non-Hodgkin Lymphoma and Nonspecific Interstitial Pneumonia during Ibrutinib Therapy

Case reports in oncological medicine, 2017-01, Vol.2017 (2017), p.1-4

2017

Volltextzugriff (PDF)

Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma In vivo: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)

Clinical cancer research, 2005-01, Vol.11 (1), p.290-297

2005

Volltextzugriff (PDF)

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy

Geburtshilfe und Frauenheilkunde, 2022-02, Vol.82 (2), p.139-180

2022

Volltextzugriff (PDF)

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

Geburtshilfe und Frauenheilkunde, 2022-02, Vol.82 (2), p.181-205

2022

Volltextzugriff (PDF)

Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis

Lung cancer (Amsterdam, Netherlands), 2022-08, Vol.170, p.165-175

2022

Volltextzugriff (PDF)

Addendum to: Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group

American journal of ophthalmology, 2020-03, Vol.211, p.233-233

2020

Volltextzugriff (PDF)

Controversies in the Treatment of Advanced Stages of Small Cell Lung Cancer

Frontiers of radiation therapy and oncology, 2010-01, Vol.42, p.193-197

2010

Volltextzugriff (PDF)

Local ablative treatment for synchronous single organ oligometastatic lung cancer—A propensity score analysis of 180 patients

Lung cancer (Amsterdam, Netherlands), 2018-11, Vol.125, p.164-173

2018

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(88)
Deutsch
(18)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(66)
Science & Technology
(66)
Humans
(61)
Oncology
(50)
Female
(39)
Biological And Medical Sciences
(36)
Male
(34)
Middle Aged
(34)
Aged
(33)
Medical Sciences
(32)
Adult
(31)
Tumors
(22)
Pharmacology. Drug Treatments
(18)
Treatment Outcome
(18)
Antineoplastic Agents
(16)
Antineoplastic Agents - Therapeutic Use
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(14)
Lung Neoplasms - Drug Therapy
(13)
Neoplasm Staging
(13)
Aged, 80 And Over
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients

First-line treatment of EGFR-mutated nonsmall cell lung cancer: critical review on study methodology

Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group

How much platinum passes the placental barrier? Analysis of platinum applications in 21 patients with cervical cancer during pregnancy

Association of Epidermal Growth Factor Receptor Polymorphism, Skin Toxicity, and Outcome in Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab-Docetaxel Treatment

Dacarbazine, Cisplatin, and Interferon-Alfa-2b With or Without Interleukin-2 in Metastatic Melanoma: A Randomized Phase III Trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma

Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy

Treatment of non-small cell lung cancer patients with the trifunctional monoclonal antibody catumaxomab (anti-EpCAM x anti-CD3): a phase I study

Eradication of EGFR-positive circulating tumor cells and objective tumor response with lapatinib and capecitabine

Phase II trial of second-line bendamustine chemotherapy in relapsed small cell lung cancer patients

Circulating Tumor Cells as Prognostic Factor for Distant Metastases and Survival in Patients with Primary Uveal Melanoma

Quantitative Detection of Circulating Tumor Cells in Cutaneous and Ocular Melanoma and Quality Assessment by Real-Time Reverse Transcriptase-Polymerase Chain Reaction

The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum

Bowel perforation in non-small cell lung cancer after bevacizumab therapy

Second-line therapy for small-cell lung cancer

A Patient with Non-Hodgkin Lymphoma and Nonspecific Interstitial Pneumonia during Ibrutinib Therapy

Addition of Histamine to Interleukin 2 Treatment Augments Type 1 T-Cell Responses in Patients with Melanoma In vivo: Immunologic Results from a Randomized Clinical Trial of Interleukin 2 with or without Histamine (MP 104)

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and Therapy

Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) – Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare Facilities

Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis

Addendum to: Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group

Controversies in the Treatment of Advanced Stages of Small Cell Lung Cancer

Local ablative treatment for synchronous single organ oligometastatic lung cancer—A propensity score analysis of 180 patients

Suchergebnisse filtern